Nutra Pharma Corp. filed its 10-K on Apr 15, 2022 for the period ending Dec 31, 2021. In this report its auditor, Rotenberg Meril Solomon Bertiger & Guttilla, P.C., gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% |
|
0.00% | +9,900.00% |
03-22 | Nutra Pharma Corporation Appoints Michael Flax as CFO | CI |
03-22 | Nutra Pharma Corporation Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 710K | |
+16.59% | 44.87B | |
-10.62% | 37.8B | |
+40.49% | 37.61B | |
+29.92% | 31.32B | |
-9.78% | 27.4B | |
+12.34% | 26.32B | |
+41.53% | 14.07B | |
+31.49% | 12.5B | |
-7.40% | 11.23B |
- Stock Market
- Equities
- NPHC Stock
- News Nutra Pharma Corp.
- Nutra Pharma Corp. Auditor Raises 'Going Concern' Doubt